Akkersestraat 50

4061Bj Ophemert



Foundation date



#Biotechnology - Therapeutics


Therapeutic areas

LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.

Upcoming events

Latest news

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

  • Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023